Gold'n Futures Mineral Corp. has appointed Curtis Riou as its new Chief Executive Officer and director, effective immediately. Riou brings over 25 years of experience in environmental consulting and resource development, enhancing the company's leadership as it advances its mineral exploration projects. The company also announced the resignation of former CEO Khaled Hatabah. This leadership change marks a new chapter for Gold'n Futures as it continues to focus on diversified resource projects.
Gold'n Futures CEO appointment news is presented with Basic Materials sector data from Pluang as of Oct 17, 2026 03:11 WIB. For readers following this sector, 42 of 83 priced US stocks rose while 41 fell. Notable movers include Gold Fields Limited (GFI) at USD 37.00 with a 4.08% increase and Pluang order activity showing 80% Sell / 20% Buy, and Harmony Gold Mining Co. (HMY) at USD 16.95 with a 4.05% rise and 88% Sell / 12% Buy activity. Johnson Controls International PLC (JCI) declined 3.69% to USD 146.82 with a typical hold time of 66 days on Pluang.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
